Arcturus Therapeutics Gets $5M

San Diego-based Arcturus Therapeutics, a developer of RNAi technology, said it has raised $5M in a Series A funding round. According to Arcturus, the funding came from multiple private capital,, high net worth investors from Canada, Japan, and the United States. Names of those capital sources were not announced. The company said the new funding will go towards recruiting a team to expand its operations and to work on its lead clinical candidate. The company is co-located with Janssen Labs in La Jolla, and is led by Joseph E. Payne. More information »